Elizabeth Galbut

Elizabeth Galbut is a venture capitalist, designer, professor, and global speaker on healthcare innovation. She is Managing Partner of SoGal Ventures which invests in diverse founding teams in the US and Asia. With over 50 investments to date, she is actively seeking to back exceptional startups revolutionizing how the next generation lives, works, and stays healthy. She recently was honored as Forbes 30 Under 30 in Venture Capital, NYC’s 33 Under 33 top innovators, and TechWeek100 Innovative Investor.

Elizabeth believes women are one of the only remaining investment arbitrage opportunities. SoGal is on a mission to redefine the next generation of founders and funders, building the foundation for gender parity for venture-backed entrepreneurs and VC investors.

SoGal Ventures is Elizabeth’s second VC firm. She co-founded A-Level Capital in 2015 at only 25 years old while in graduate school at Johns Hopkins. The start of Elizabeth’s VC career was personal – during grad school her father was diagnosed with cancer, while at the same time she was advising digital pathology startup, Proscia. The startup was facing difficulty raising their initial seed round, and she knew first-hand how necessary the new technology was for improving the diagnostic process for cancer. She made it her mission to be the first outside investor into the company, so other families wouldn’t have to endure the pain that hers did. A-Level Capital wrote the first check and by the time the CEO graduated a few months later, he closed an oversubscribed seed round to bring his technology to market.

Elizabeth’s favorite investment area is the intersection of smart design and machine learning/AI fueling major health tech innovation. Her portfolio of digital health startups include lab platform Everlywell, sexual wellness brand Unbound, digital pathology analytics pioneer Proscia, medication adherence tech eMocha, smart water bottle Hidrate, AI-powered drug discovery Insilico Medicine, smart socks Siren Care, data-driven skincare technology HelloAva, asthma management tool Tueo Health, and physician authorization system Glidian.

Elizabeth is also involved in innovation through her role as faculty member at the School of Visual Arts MFA Products of Design graduate program, a global keynote speaker on the topics of healthcare innovation, venture capital, cross-border business, and venture design, and an investment committee member for Technology Development Corporation (TEDCO).

Prior to graduate studies, as a Strategy and Operations Consultant at Deloitte Consulting, Elizabeth focused her attention on developing long-term strategy for a variety of large healthcare clients. She contributed to business development efforts leading to over $200M of new work. Elizabeth is an alumnus of Georgetown University, London School of Economics, Johns Hopkins University, and Maryland Institute College of Art.